| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
P3 Health Partners (NASDAQ:PIII) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
P3 Health Partners missed estimated earnings by -100.0%, reporting an EPS of $-0.22 versus an estimate of $-0.11.
Revenue was up $88.66 million from the same period last year.
Last quarter the company beat on EPS by $0.1 which was followed by a 6.0% increase in the share price the next day.
Here's a look at P3 Health Partners's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.22 | -0.24 | -0.67 | -0.91 |
| EPS Actual | -0.12 | -0.09 | -0.22 | -2.26 |
| Revenue Estimate | 293.42M | 303.30M | 282.90M | 252.95M |
| Revenue Actual | 288.35M | 329.09M | 302.08M | 258.20M |
To track all earnings releases for P3 Health Partners visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: PIII
